TY - JOUR
T1 - Nitric oxide, normal science, and lessons learned by a marginally prepared mind
AU - Joyner, Michael J.
N1 - Funding Information:
This work on NO in humans has been supported by the American Heart Association, NIH, and the Mayo Foundation. The author is indebted to his collaborators, fellows, and students, as well as to the many volunteer participants. None of this would have been possible without the dedication of the research nurses and technical support staff. Thanks also to Virginia Miller, Kathryn Larson, and John-Roger Shepherd for helpful reviews of earlier drafts of this manuscript. Any ideas expressed in this essay are the author’s own and not those of his collaborators, institution, or any funding agency.
Publisher Copyright:
© 2018 by Johns Hopkins University Press.
PY - 2018/3/1
Y1 - 2018/3/1
N2 - The discovery in the late 1970s that the vascular endothelium plays a major role in regulating the caliber of blood vessels caused a minor paradigm shift in thinking about the cardiovascular system. That the gas nitric oxide (NO) was central to this discovery was unexpected and set the stage for a broader series of insights related to gaseous signaling molecules in biological systems. Over the last 25 years, the author’s lab has attempted to understand what NO does in alive, awake, exercising humans. This article recounts six lessons learned along the way, about luck, reductionism, and the translation of biomedical discoveries to therapy, as well as about philosophical questions related to big versus small science and curiosity-driven versus goal-directed approaches. The article also poses a fundamental question: would NO in specific and gaseous signaling molecules more generally have been discovered by sequencing, Big Data, and hypothesis-free science?.
AB - The discovery in the late 1970s that the vascular endothelium plays a major role in regulating the caliber of blood vessels caused a minor paradigm shift in thinking about the cardiovascular system. That the gas nitric oxide (NO) was central to this discovery was unexpected and set the stage for a broader series of insights related to gaseous signaling molecules in biological systems. Over the last 25 years, the author’s lab has attempted to understand what NO does in alive, awake, exercising humans. This article recounts six lessons learned along the way, about luck, reductionism, and the translation of biomedical discoveries to therapy, as well as about philosophical questions related to big versus small science and curiosity-driven versus goal-directed approaches. The article also poses a fundamental question: would NO in specific and gaseous signaling molecules more generally have been discovered by sequencing, Big Data, and hypothesis-free science?.
UR - http://www.scopus.com/inward/record.url?scp=85052298718&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052298718&partnerID=8YFLogxK
U2 - 10.1353/pbm.2018.0036
DO - 10.1353/pbm.2018.0036
M3 - Article
C2 - 30146518
AN - SCOPUS:85052298718
SN - 0031-5982
VL - 61
SP - 191
EP - 200
JO - Perspectives in Biology and Medicine
JF - Perspectives in Biology and Medicine
IS - 2
ER -